The ExoDxTM Prostate Test is a urine‐based test to determine the probability of clinically significant prostate cancer in men with PSA 2–10 ng/mL (“gray zone”) who are considering an initial biopsy.45 This evidence concerns the gene KLK3 and prostate cancer.